Tibet AIM Pharm. Inc. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 338.753 million compared to CNY 248.707 million a year ago. Operating income was CNY 14.584 million compared to CNY 11.343 million a year ago. Net income was CNY 10.177 million compared to CNY 13.189 million a year ago. Basic earnings per share from continuing operations was CNY 0.05 compared to CNY 0.07 a year ago.